BlueWind Medical System for the Treatment of Patients With OAB (OAB)
Safety and Performance of the BlueWind System for the Treatment of Patients With Overactive Bladder (OAB) Amended to Allow Extended Follow up of the Patients
Sponsor: BlueWind Medical
Listed as NCT02299544, this NA trial focuses on Over Active Bladder and remains completed. Sponsored by BlueWind Medical, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Jul 2019 — May 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Dec 2018 — Jul 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting · Phase: PHASE1 → NA
-
Oct 2017 — May 2018 [monthly]
Unknown Status PHASE1
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BlueWind Medical
For direct contact, visit the study record on ClinicalTrials.gov .